Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00773136 · ClinicalTrials.gov registry record · NA
Eyelash Growth From Application of Bimatoprost in Gel Suspension to the Base of the Eyelashes
A NA study, sponsored by University of Miami.
- Completed
- Registry status
- NA
- Development phase
- 21
- Enrollment target
NCT00773136 is a NA study that has completed, run by University of Miami. The registered enrollment target is 21 participants.
The verdict
NCT00773136, a NA study, has completed, sponsored by University of Miami.
- COMPLETED
- Registry status
- NA
- Development phase
- 21 participants
- Enrollment target
Study Summary
Objective: To determine if Lumigan (bimatoprost) causes increased lash length when used in gel suspension applied to the base of the eyelashes. Methods: Subjects recruited from the Bascom Palmer Eye Institute were screened and those who met inclusion criteria were enrolled. Each participant received two vials of gel suspension, which contained bimatoprost and normal saline, respectively, each mixed 1:1 with GonakTM gel and labeled "right eye" and "left eye" according to randomization. The suspension was applied to the eyelashes every evening on the designated eye for 6 weeks. Lash length was measured with a caliper at enrollment, at weekly intervals during the study and at 1 and 3 months after study completion. Visual acuity, ocular symptoms, intraocular pressure and photographs were documented at these same intervals. Results: The average eyelash growth in the Lumigan group was 2.01mm (vs. control average of 1.13mm) which was a statistically significant difference (p=0.009). The average intraocular pressure decreased equally in both groups (2.14 mmHg). No change in visual acuity or iris discoloration was noted in any of the subjects. Discussion: Our data showed an increase in eyelash length with use of Lumigan in gel suspension, suggesting that it may have eyelash lengthening properties.
Interventions
- DRUG Bimatoprost Suspension
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 21 participants |
| Start Date | 2008-02 |
| Est. Completion | 2008-07 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00773136
The ClinicalTrials.gov registry entry for NCT00773136 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 21 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Miami, which has 721 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Bimatoprost Suspension is the first listed.
NCT00773136 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00773136 about?
NCT00773136 is a clinical study titled "Eyelash Growth From Application of Bimatoprost in Gel Suspension to the Base of the Eyelashes". Objective: To determine if Lumigan (bimatoprost) causes increased lash length when used in gel suspension applied to the base of the eyelashes. Methods: Subjects recruited from the Bascom Palmer Eye Institute were screened and those who met inclusion criteria were enrolled. Each participant received...
What is the current status of trial NCT00773136?
This trial is currently completed. It is a NA study. The enrollment target is 21 participants. The study started on 2008-02. Estimated completion is 2008-07.
What interventions are being tested in trial NCT00773136?
The interventions under investigation include: Bimatoprost Suspension (DRUG).
Who is sponsoring clinical trial NCT00773136?
This trial is sponsored by University of Miami, which has 721 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.